DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

43.23 -0.53 (-1.21%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $43.23 -1.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.85
Previous Close $43.76
Daily Range $42.80 - $44.39
52-Week Range $30.05 - $44.95
Market Cap $5.4B
P/E Ratio -66.30
Dividend (Yield) $0.00 (0.0%)
Volume 873,790
Average Daily Volume 1,201,275
Current FY EPS -$0.76

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Insiders keep on buying Macerich Co and Seattle Genetics

Trade-Ideas: Seattle Genetics (SGEN) Is Today's Post-Market Leader Stock

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) Is Today's Perilous Reversal Stock

Insider Trading Alert - SGEN, NSP And TSCO Traded By Insiders

Insider Weekends - May 8, 2015

Seattle Genetics director buys more than 1 million shares

See More SGEN News...

SGEN's Top Competitors

SGEN $43.23 (-1.21%)
Current stock: SGEN
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB